The Effects of Synaquell on Brain Function
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to investigate the dietary supplement, Synaquell (TM), for effects on brain function.
Full description
Ice Hockey players will be administered Synaquell over the course of one season. Each player will be administered Synaquell or a placebo twice, daily. They will be tested during the preseason and the postseason to compare changes in cognitive measures. This is an optimal population, as Synaquell was designed for contact sport athletes and others sustaining frequent head impacts.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- 18 years of age or greater.
- Fluent English speakers.
- Medically cleared to play ice hockey.
Exclusion criteria
- An allergy to the ingredients of Synaquell or Synaquell+ (Magnesium, beta hydroxybutyrate, Glutathione, N-acetyl-L-cysteine, Riboflavin, Magnesium, Leucine, Isoleucine, Valine, Resveratrol, Curcumin Phytosome, Nicotinamide riboside, Docosahexanoic Acid).
- Clinically documented hearing issues.
- In-ear hearing aid or cochlear implant.
- Implanted pacemaker or defibrillator.
- Metal or plastic implants in skull.
- Lack of verbal fluency in the English language.
- History of seizures.
- Allergy to rubbing alcohol or EEG gel.
- Unhealthy scalp.
Trial design
Primary purpose
Allocation
Interventional model
Masking
54 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal